SA
ABMD logo
Abiomed, Inc.(ABMD)
Closing price · checked 4:30 PM ETAbout this dataData status
$381.02▲0.00 (0.00%)

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Abiomed, Inc. (ABMD)

R&D to Revenue

15.84%

Fiscal year · Period ending:

ABMD logo

ABMD R&D to Revenue

Latest reported15.84%
ABMD FY R&D/Revenue (0.00% → 15.84%)
Powered by
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

ABMD r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Abiomed, Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to RevenueChange
15.8374%+1.46 pts
14.3802%+2.64 pts
11.7447%−0.41 pts
12.1522%−0.53 pts
12.6816%−2.23 pts
14.908%−0.19 pts
15.0994%−0.52 pts
15.6193%−1.10 pts
16.721%+0.50 pts
16.2195%−5.27 pts
21.4908%−4.88 pts
26.3734%−3.91 pts
30.2801%−4.32 pts
34.5964%−7.68 pts
42.2745%−1.74 pts
44.0127%−24.79 pts
68.8001%+33.48 pts
35.3177%−20.24 pts
55.5538%−32.61 pts
88.1682%−13.73 pts
101.8989%+10.84 pts
91.0628%+21.64 pts
69.4275%+8.54 pts
60.8873%+20.38 pts
40.5035%+17.22 pts
23.2839%−1.77 pts
25.0545%−2.12 pts
27.1739%−8.65 pts
35.8209%+35.82 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%—

Frequently asked questions: ABMD r&d to revenue

What is Abiomed, Inc. (ABMD)'s current r&d to revenue?

Abiomed, Inc. (ABMD)'s latest reported r&d to revenue (Fiscal year) is 15.84% as of Mar 31, 2022. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for ABMD?

Stock Alarm Pro provides 36 dated annual fiscal periods observations for Abiomed, Inc. (ABMD)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ABMD's r&d to revenue to peers or set an alert?

You can open ABMD's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ABMD delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.